SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-001410
Filing Date
2018-01-09
Accepted
2018-01-09 08:00:26
Documents
3
Period of Report
2018-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv482923_8k.htm 8-K 21153
2 EXHIBIT 10.1 tv482923_ex10-1.htm EX-10.1 287230
3 GRAPHIC image_001.jpg GRAPHIC 5687
  Complete submission text file 0001144204-18-001410.txt   317686
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 18517866
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1